TCM Biotech International Corp. (TPE:4169)
Taiwan
· Delayed Price · Currency is TWD 158.00
+0.50 (0.32%)
At close: Apr 29, 2026
TCM Biotech International Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 19.17 | 21.01 | 18.57 | 18.27 | 1.87 | Upgrade
|
| Depreciation & Amortization | 22 | 22.03 | 20.2 | 18.41 | 16.46 | Upgrade
|
| Other Amortization | 1.53 | 1.84 | 1.69 | 1.59 | 1.59 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.08 | -0.72 | -0.8 | - | -0.91 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.67 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | 1.95 | - | 1.73 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.65 | -0.69 | - | 0.48 | - | Upgrade
|
| Other Operating Activities | -0.99 | 1.33 | 1.02 | 6.19 | -3.14 | Upgrade
|
| Change in Accounts Receivable | -18.26 | 120.47 | -27.69 | -35.13 | -22.2 | Upgrade
|
| Change in Inventory | -12.72 | 50.65 | -13.34 | 4.75 | -3.27 | Upgrade
|
| Change in Accounts Payable | 29.55 | -43.32 | -18.69 | 24.47 | 18.14 | Upgrade
|
| Change in Unearned Revenue | 7.45 | 0.59 | 2.72 | -20.55 | 1.31 | Upgrade
|
| Change in Other Net Operating Assets | -9.54 | -5.76 | -23.17 | 33.77 | 3.74 | Upgrade
|
| Operating Cash Flow | 37.13 | 167.42 | -37.54 | 52.24 | 15.33 | Upgrade
|
| Operating Cash Flow Growth | -77.82% | - | - | 240.86% | -79.54% | Upgrade
|
| Capital Expenditures | -2.49 | -8 | -3.98 | -3.78 | -4.14 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.17 | 1.28 | 1.33 | - | 1.96 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.34 | -0.35 | -0.94 | -1.51 | -3.58 | Upgrade
|
| Investment in Securities | - | -330 | - | -0.09 | - | Upgrade
|
| Other Investing Activities | 3.7 | -3.32 | -0.94 | -2.71 | -13.85 | Upgrade
|
| Investing Cash Flow | 3.04 | -340.4 | -4.52 | -8.09 | -19.61 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 44 | Upgrade
|
| Long-Term Debt Issued | - | - | 30 | - | - | Upgrade
|
| Total Debt Issued | - | - | 30 | - | 44 | Upgrade
|
| Short-Term Debt Repaid | - | -44 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -7.37 | -37.09 | -72.08 | -12.55 | -11.94 | Upgrade
|
| Total Debt Repaid | -7.37 | -81.09 | -72.08 | -12.55 | -11.94 | Upgrade
|
| Net Debt Issued (Repaid) | -7.37 | -81.09 | -42.08 | -12.55 | 32.06 | Upgrade
|
| Issuance of Common Stock | - | - | 500 | - | 13.09 | Upgrade
|
| Common Dividends Paid | -20.67 | -16.83 | -1.62 | - | -16.92 | Upgrade
|
| Other Financing Activities | - | -0.27 | - | 0.11 | - | Upgrade
|
| Financing Cash Flow | -28.04 | -98.19 | 456.3 | -12.44 | 28.24 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.04 | 0.02 | 0.04 | -0.12 | 0.03 | Upgrade
|
| Net Cash Flow | 12.09 | -271.15 | 414.29 | 31.59 | 23.99 | Upgrade
|
| Free Cash Flow | 34.65 | 159.42 | -41.51 | 48.46 | 11.19 | Upgrade
|
| Free Cash Flow Growth | -78.27% | - | - | 333.15% | -84.45% | Upgrade
|
| Free Cash Flow Margin | 5.05% | 23.92% | -4.28% | 6.04% | 1.59% | Upgrade
|
| Free Cash Flow Per Share | 0.59 | 2.70 | -0.78 | 0.99 | 0.23 | Upgrade
|
| Cash Interest Paid | 0.86 | 1.61 | 2.77 | 2.39 | 1.97 | Upgrade
|
| Cash Income Tax Paid | 4.12 | 2.57 | 2.44 | - | 3.53 | Upgrade
|
| Levered Free Cash Flow | 29.83 | 146.85 | -42.01 | 63.66 | 11.11 | Upgrade
|
| Unlevered Free Cash Flow | 30.37 | 147.85 | -40.28 | 65.15 | 12.34 | Upgrade
|
| Change in Working Capital | -3.52 | 122.63 | -80.18 | 7.3 | -2.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.